Nephros Exhibiting at Denver, Colorado APIC Conference June...(The Nephros DSU delivers by offeringexce...),Health

"In a healthcare facility, high-risk immuno-compromised patients require a higher standard of water than tap or bottled water. Our disposable, cold-sterilizing-grade filter (0.005 microns membrane) far exceeds the CDC recommendation of 0.2 microns (bacterial) filtration, producing biologically pure water for sinks and showers," said Joleen Turner, Nephros's Vice President of Marketing.

The Nephros DSU point-of-use filter was installed and tested at major northeast medical centers as a proactive measure to prevent the spread of Legionella and other potentially lethal pathogens. The DSU filter provided an effective barrier from waterborne microbial contamination and demonstrated exceptional product longevity.

About Nephros, Inc.

Nephros, Inc., headquartered in New York, is a medical device company developing and marketing products designed to improve the quality of life for the End-Stage Renal Disease (ESRD) patient, while addressing the critical financial and clinical needs of the care provider. ESRD is a disease state characterized by the irreversible loss of kidney function. Nephros products are sold and distributed throughout Europe and are currently being used in over fifty clinics in Europe.

Nephros also markets a line of water filtration products incorporating its patented dual stage cold sterilization filtration technology, the Dual Stage Ultrafilter (DSU), which produces biologically safe water. The DSU has the capability to filter out bacteria and, due to its exceptional filtration levels, filter out many viruses, parasites, and other biotoxins as well. The DSU is in a pilot-use program at a major U.S. medical center and has been selected for further development by the U.S. Marine Corps.

For more information on Nephros, please visit the Company's website at